'Amazing' Results With Drug Combo in Metastatic Cervical Cancer

(MedPage Today) -- SAN JUAN, Puerto Rico -- The investigational antibody-drug conjugate sacituzumab tirumotecan plus pembrolizumab (Keytruda) demonstrated encouraging antitumor activity in patients with recurrent or metastatic cervical cancer...
Source
MedPage Today
Opens original article in a new tab



